On Tuesday, the House Energy & Commerce Subcommittee on Health held a field hearing at the Scripps Seaside Forum, Scripps Institution of Oceanography in San Diego, CA. The field hearing was entitled "Impact of Medical Device and Drug Regulation on Innovation, Jobs and Patients: A Local Perspective." Congressman Brian Bilbray was honored to be joined by the Honorable Michael C. Burgess, M.D., Vice Chairman of the Subcommittee on Health. Also in attendance were local life-science industry representatives from the California Healthcare Institute (CHI), Conataus Pharmaceuticals, West Wireless Health Institute, BIOCOM, and CONNECT to provide first hand testimony. Please see the below opening statement prepared by Congressman Brian Bilbray on the importance of the life-sciences community in San Diego:
"California, and particularly San Diego, is home to many of the most exciting and advanced life science companies in the world. The San Diego life science cluster is one of the largest in the world. There are approximately 40,000 employees at more than 700 companies, including biotechnology, medical device, diagnostic companies, and research institutes. San Diego is internationally recognized for its innovation, producing some of most important discoveries in the world.
It is no secret that the best markets are the freest markets. Removing government barriers to job growth is necessary in any business, whether it be in a biotech company looking for the cure for cancer or a device company making an artificial pancreas for a diabetic. Unfortunately, we have seen the FDA put up roadblock after roadblock for companies looking to expand their businesses and develop the next great breakthrough."